When Ryan Van Laar created his molecular diagnostics and personalized medicine research company, ChipDX, two years ago, he aimed to provide clinicians with a cheaper and easier way to identify the best treatment solutions for cancer patients. "I had the idea [for ChipDX] thinking about the existing model of clinical diagnostics, where a clinician orders a test and then sends the specimen to a remote laboratory where a genetic profile is generated and then one small set of genes is used to generate a result," Van Laar says.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.